Skip to main content
. 2014 Jan 28;5(6):1515–1525. doi: 10.18632/oncotarget.1765

Table 5B. Summary of OS Stratified by TERT promoter and IDH1/2 Mutational Status in Grades III and IV.

OS in months (95% CI) 1 year OS (95% CI) 2 year OS (95% CI) 5 year OS (95% CI) 10 year OS (95% CI)
TERT MUT / IDH WT 187 168 11.5
(10.0, 14.0)
48.5%
(41.0%, 55.7%)
16.4%
(11.3%, 22.4%)
1.9%
(0.5%, 5.5%)
1.0%
(0.1%, 4.4%)
TERT WT / IDH WT 50 37 17.2
(10.5, 26.2)
61.4%
(45.9%, 73.7%)
35.9%
(21.8%, 50.2%)
10.4%
(3.0%, 23.2%)
10.4%
(3.0%, 23.2%)
TERT WT / IDH MUT 82 40 56.9
(38.8, 66.2)
87.8%
(77.8%, 93.5%)
76.2%
(63.9%, 84.8%)
44.3%
(30.6%, 57.1%)
30.3%
(18.0%, 43.6%)
TERT MUT / IDH MUT 42 18 125.2
(54.7, 197.2)
92.2%
(77.8%, 97.4%)
83.2%
(66.2%, 92.1%)
62.7%
(43.4%, 77.1%)
53.9%
(33.9%, 70.2%)